Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05837936 · ClinicalTrials.gov registry record
Total Intravenous Anesthesia (TIVA)/Sevoflurane Initiated Intravenous Anesthesia (SIIVA) in Pediatric Patients
A clinical trial of Extubation, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 600
- Enrollment target
- 2
- Study locations
NCT05837936: Recruiting study of Extubation, sponsored by Wake Forest University Health Sciences.
NCT05837936 is a study of Extubation that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 600 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05837936, a study of Extubation, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
Because Propofol is the primary "anesthetic agent," and inhalational agents remain in trace quantities at the end of the procedure Sevoflurane initiated intravenous anesthesia (SIIVA) or not present at all Total intravenous anesthesia (TIVA) it is likely that different criteria may be predictive of extubation success in these patients compared to inhalational anesthesia.
Primary Outcome
quality of extubation will be assess using a standard rubric for all extubation
Conditions Studied
Interventions
- OTHER Total intravenous anesthesia (TIVA)
- OTHER Sevoflurane initiated intravenous anesthesia (SIIVA)
Study Locations (2)
North Carolina
- Atrium Health Wake Forest Baptist - Winston-Salem
Other
- Perth Children's Hospital - Perth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2023-03-28 |
| Est. Completion | 2028-03 |
What NCT05837936 shows while recruiting
NCT05837936 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Extubation appearing as the primary indexed condition, and to 2 interventions - of which Total intravenous anesthesia (TIVA) is the first listed.
NCT05837936 reports a single indexed study location in North Carolina, Other.
Frequently Asked Questions
What is clinical trial NCT05837936 about?
NCT05837936 is a clinical study titled "Total Intravenous Anesthesia (TIVA)/Sevoflurane Initiated Intravenous Anesthesia (SIIVA) in Pediatric Patients". Because Propofol is the primary "anesthetic agent," and inhalational agents remain in trace quantities at the end of the procedure Sevoflurane initiated intravenous anesthesia (SIIVA) or not present at all Total intravenous anesthesia (TIVA) it is likely that different criteria may be predictive of ...
What is the current status of trial NCT05837936?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2023-03-28. Estimated completion is 2028-03.
What conditions does trial NCT05837936 study?
This clinical trial studies the following conditions: Extubation.
What interventions are being tested in trial NCT05837936?
The interventions under investigation include: Total intravenous anesthesia (TIVA) (OTHER), Sevoflurane initiated intravenous anesthesia (SIIVA) (OTHER).
Who is sponsoring clinical trial NCT05837936?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05837936 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Extubation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI